Form 8-K - Current report:
SEC Accession No. 0000950170-25-035544
Filing Date
2025-03-07
Accepted
2025-03-07 16:30:07
Documents
13
Period of Report
2025-03-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K meip-20250303.htm   iXBRL 8-K 58266
2 EX-10.1 meip-ex10_1.htm EX-10.1 79382
3 GRAPHIC img265156357_0.jpg GRAPHIC 20892
  Complete submission text file 0000950170-25-035544.txt   282519

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT meip-20250303.xsd EX-101.SCH 24867
15 EXTRACTED XBRL INSTANCE DOCUMENT meip-20250303_htm.xml XML 4705
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41827 | Film No.: 25720530
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)